# Task A53: High Throughput Evaluation of COVID-19 Therapeutics in Small Animal Models

> **NIH NIH N01** · UTAH STATE UNIVERSITY · 2021 · $190,041

## Abstract

This contract provides for the development and standardization of small animal models of infectious diseases, and may include efficacy testing of candidate products, including GLP studies to support licensure

## Key facts

- **NIH application ID:** 10475975
- **Project number:** 272201700041I-0-759302100002-2
- **Recipient organization:** UTAH STATE UNIVERSITY
- **Principal Investigator:** BART TARBET
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $190,041
- **Award type:** —
- **Project period:** 2021-03-29 → 2022-03-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10475975

## Citation

> US National Institutes of Health, RePORTER application 10475975, Task A53: High Throughput Evaluation of COVID-19 Therapeutics in Small Animal Models (272201700041I-0-759302100002-2). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10475975. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*